Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of some unusual options trading on Wednesday. Stock traders purchased 1,885 put options on the company. This represents an increase of approximately 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Price Performance

Evelo Biosciences has a 12 month low of $0.00 and a 12 month high of $5.27. The company’s 50-day moving average is $0.03 and its 200-day moving average is $0.04. The firm has a market cap of $2,000.00, a P/E ratio of 0.00 and a beta of 1.59.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.